Clinical Trials Logo

Filter by:
NCT ID: NCT04530370 Recruiting - Covid19 Clinical Trials

Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients

Start date: May 29, 2020
Phase: Early Phase 1
Study type: Interventional

The discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the outbreak of coronavirus disease 2019 (COVID-19) are causing public health emergencies. A handful pieces of literature have summarized its clinical and radiologic features, whereas therapies for COVID-19 are rather limited. To evaluate the efficacy of convalescent plasma therapy in COVID-19 patients.

NCT ID: NCT04529668 Recruiting - Clinical trials for Vitamin D Deficiency, Nasal Polyposis

Effect of Vitamin d Deficiency in Chronic Rhinosinusitis With Nasal Polyposis

Start date: October 1, 2015
Phase: Phase 1
Study type: Interventional

Aim of the work 1. To determine if chronic rhinosinusitis with nasal polyps' (CRSwNP) populations are vitamin D deficient. 2. To determine the possible anti-inflammatory effect of vitamin D supplementation (clinically & histologically). & investigate its relation to immunohistochemical tissue expression of basic fibroblast growth factor

NCT ID: NCT04529122 Recruiting - Solid Tumours Clinical Trials

A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test

Start date: August 27, 2020
Phase:
Study type: Observational [Patient Registry]

WAYFIND-R is a registry that aims to capture high-quality real-world data linking next-generation sequencing, treatments and outcomes from cancer patients diagnosed with a solid tumour. The WAYFIND-R has three main overarching objectives: 1. To provide a platform to support the design and conduct of clinical and epidemiological research; 2. To develop an evidence-generation platform to better understand health outcomes and cancer care processes; and 3. To characterize the treatments and clinical course of solid tumor cancers in patients who have undergone NGS testing.

NCT ID: NCT04528329 Recruiting - Covid19 Clinical Trials

Anosmia and / or Ageusia and Early Corticosteroid Use

Start date: March 30, 2021
Phase: Phase 4
Study type: Interventional

Time to recover of Anosmia and / or ageusia and early corticosteroid use

NCT ID: NCT04527835 Recruiting - Viral Myocarditis Clinical Trials

Presentation, Clinical Course and Patterns of Myocardial Damage Due to Viral Myocarditis

Start date: October 1, 2020
Phase:
Study type: Observational

Presentation, Clinical Course and Patterns of Myocardial Damage due to Viral Myocarditis

NCT ID: NCT04524754 Recruiting - Anosmia Clinical Trials

Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients With COVID-19

Start date: July 11, 2020
Phase:
Study type: Observational

Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients with COVID-19

NCT ID: NCT04520568 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

High Flow Nasal Cannula Oxygen During Sedation for Video-assisted Thoracoscopic Surgery

Start date: August 1, 2020
Phase: Phase 2
Study type: Interventional

High-flow nasal cannula (HFNC) is a device that delivers10 to 70 L min-1 of heated, humidified 100% oxygen via nasal route. It provides positive airway pressure, decreases dyspnea, decreases the work of breathing, and improves comfort

NCT ID: NCT04519281 Recruiting - Clinical trials for to Study the Effect of Vitamin C Administration on the Amount and the Time of Weaning of Noradrenaline Given Post-operatively to Patients After CPB

Role of Vitamin C in Cardiac Vasoplegia After Cardiopulmonary Bypass

Start date: April 16, 2020
Phase:
Study type: Observational [Patient Registry]

This is a parallel group double-blind, randomized-controlled trial with 1:1 randomization ratio which will be conducted over a period of 6 months to study the effect of vitamin C administration on the amount of noradrenaline given post-operatively to patients after CPB. Two groups will be included; Group (A) patients undergoing open heart surgeries who will receive IV ascorbic acid (treatment group) and Group (B) patients undergoing open heart surgeries who will not receive ascorbic acid or will receive a placebo (control group). Each patient will be subjected to assessments of the doses of noradrenaline given from the end of surgery until weaning as well as hemodynamics in the first 2 hours and then at intervals of 6 hours up to 3 days following surgery.

NCT ID: NCT04518189 Recruiting - Infertility, Female Clinical Trials

Transdermal Lidocaine for Pain Control During Hysterosalpingography

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

the study aims to investigate the effectiveness of Transdermal lidocaine patch for Pain Control During Hysterosalpingography

NCT ID: NCT04518176 Recruiting - Clinical trials for Cesarean Section Complications

Bilateral Uterine Artery Ligation During the Cesarean Delivery of Twins

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

Objective to assess the effectiveness of prophylactic bilateral uterine artery ligation (BUAL) in reducing the incidence of postpartum hemorrhage during cesarean delivery among women with twin pregnancy